GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » Net Interest Income

Optimind Pharma (XCNQ:OMND) Net Interest Income : C$-0.01 Mil (TTM As of Nov. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Optimind Pharma Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Optimind Pharma's net interest income for the three months ended in Nov. 2024 was C$0.00 Mil. Its net interest income for the trailing twelve months (TTM) ended in Nov. 2024 was C$-0.01 Mil.

Optimind Pharma Net Interest Income Historical Data

The historical data trend for Optimind Pharma's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimind Pharma Net Interest Income Chart

Optimind Pharma Annual Data
Trend Feb22 Feb23 Feb24
Net Interest Income
- -0.07 -0.09

Optimind Pharma Quarterly Data
Jun21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 -0.01 - - -

Optimind Pharma Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Optimind Pharma Net Interest Income Related Terms

Thank you for viewing the detailed overview of Optimind Pharma's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Optimind Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » Net Interest Income
Comparable Companies
XCNQ:VENI XCNQ:PHRX XCNQ:MGW XCNQ:VIBE XCNQ:STRC.X TSX:WLLW XCNQ:JOLT XCNQ:OVAT TSXV:LFST TSXV:AQS ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
77 King Street West, Suite 3000, TD Centre, North Tower, PO Box 95, Toronto, ON, CAN, M5K 1G8
Website
https://www.optimindpharma.com
Optimind Pharma Corp is an emerging provider of psychedelic therapies for the masses. It helps people suffering from PTSD, Anxiety, Depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities. It is also partnered with developers of psilocybin-associated treatments and products to further expand its treatment and program offerings.

Optimind Pharma Headlines

No Headlines